Gradient Investments LLC Invests $20.06 Million in Intuitive Surgical, Inc. $ISRG

Gradient Investments LLC bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, Holdings Channel reports. The institutional investor bought 35,412 shares of the medical equipment provider’s stock, valued at approximately $20,056,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Regent Peak Wealth Advisors LLC grew its position in Intuitive Surgical by 5.6% during the fourth quarter. Regent Peak Wealth Advisors LLC now owns 760 shares of the medical equipment provider’s stock valued at $430,000 after acquiring an additional 40 shares during the period. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Intuitive Surgical by 3.8% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 140,963 shares of the medical equipment provider’s stock worth $84,149,000 after purchasing an additional 5,206 shares during the period. NorthCrest Asset Manangement LLC lifted its stake in shares of Intuitive Surgical by 4.2% in the 4th quarter. NorthCrest Asset Manangement LLC now owns 21,865 shares of the medical equipment provider’s stock valued at $12,384,000 after purchasing an additional 881 shares in the last quarter. Grove Bank & Trust lifted its stake in shares of Intuitive Surgical by 129.4% in the 4th quarter. Grove Bank & Trust now owns 2,936 shares of the medical equipment provider’s stock valued at $1,663,000 after purchasing an additional 1,656 shares in the last quarter. Finally, Gryphon Financial Partners LLC grew its holdings in shares of Intuitive Surgical by 6.5% during the 4th quarter. Gryphon Financial Partners LLC now owns 1,386 shares of the medical equipment provider’s stock worth $785,000 after purchasing an additional 84 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Myriam Curet sold 105 shares of the business’s stock in a transaction dated Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total value of $51,864.75. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Mark Brosius sold 645 shares of the stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $485.01, for a total value of $312,831.45. Following the completion of the transaction, the senior vice president directly owned 1,613 shares of the company’s stock, valued at $782,321.13. This represents a 28.57% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 32,943 shares of company stock valued at $17,279,568 in the last three months. 0.60% of the stock is owned by insiders.

Intuitive Surgical Trading Down 0.5%

Shares of ISRG stock opened at $477.76 on Monday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $603.88. The company has a market capitalization of $169.67 billion, a PE ratio of 60.55, a price-to-earnings-growth ratio of 3.69 and a beta of 1.66. The firm has a fifty day simple moving average of $502.83 and a 200-day simple moving average of $513.46.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The firm had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm’s revenue was up 18.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.21 EPS. Equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on ISRG shares. UBS Group dropped their target price on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research report on Tuesday, March 17th. TD Cowen upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research note on Tuesday, January 27th. Argus dropped their price objective on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. Finally, Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $614.95.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Fundamentals remain strong — Intuitive reported an earnings beat and double‑digit revenue growth in its latest quarter, supporting the company’s long‑term growth thesis and valuation premium. Bull of the Day: Intuitive Surgical (ISRG)
• Positive Sentiment: Prominent bullish mentions — coverage including a “Bull of the Day” piece and a Jim Cramer mention keep ISRG on the buy/hold radar for growth investors, which can support buying interest after negative headlines. Jim Cramer Analyzed 5 Stocks
• Neutral Sentiment: Comparative analyses and sector commentary (head‑to‑head pieces) provide context but no immediate catalyst; these may influence longer‑term positioning rather than intraday moves. Head‑To‑Head Analysis: Lombard Medical & Intuitive Surgical
• Negative Sentiment: FDA safety flag on stapler devices — regulators have flagged safety concerns and advised halting affected devices, which is a near‑term operational and reputational risk that likely pressured the stock. FDA Flags Safety Concern Over Intuitive Surgical Stapler
• Negative Sentiment: Company warning and reported death related to stapler reloads — Intuitive issued warnings after at least one reported death, increasing legal, recall and adoption‑risk concerns for affected products. Intuitive warns on surgical stapler reloads with one death reported
• Negative Sentiment: Broader quality and cybersecurity scrutiny — reporting highlights recalls and other operational snags (including cyber incidents), which amplify investor uncertainty about near‑term execution and regulatory exposure. From Cyber Criminals to Recalls: Inside Intuitive Surgical’s Newest Snag
• Negative Sentiment: Technical weakness — the stock recently formed a “death cross” (50‑day moving average crossing below the 200‑day), which can trigger momentum selling from technical traders even if fundamentals remain solid. Intuitive Surgical Stock Just Flashed A Death Cross

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.